PT  - JOURNAL ARTICLE
AU  - SOGAND SCHAFER
AU  - HAYDER AL-QADDO
AU  - MARTIN GOSAU
AU  - RALF SMEETS
AU  - PHILIP HARTJEN
AU  - REINHARD E. FRIEDRICH
AU  - OLA A. NADA
AU  - TOBIAS VOLLKOMMER
AU  - ASHKAN RASHAD
TI  - Cytocompatibility of Bone Substitute Materials and Membranes
AID  - 10.21873/invivo.12472
DP  - 2021 Jul 01
TA  - In Vivo
PG  - 2035--2040
VI  - 35
IP  - 4
4099  - http://iv.iiarjournals.org/content/35/4/2035.short
4100  - http://iv.iiarjournals.org/content/35/4/2035.full
SO  - In Vivo2021 Jul 01; 35
AB  - Background/Aim: With the demographic change and associated chronic bone loss, the need for cytocompatible bone replacement materials arise in modern medicine. The aim of this in vitro study was to investigate the cytocompatibility of eleven different bone substitute materials and membranes. Materials and Methods: Seven bone substitute materials and four membranes were assessed in vitro. The specimens were tested based on their interaction with MC3T3 pre-osteoblasts, through the utilization of viability, proliferation, and cytotoxicity assays. Cell vitality was evaluated using live-dead staining. Results: Although we found minor differences in cytocompatibility among the assessed materials, all tested materials can be considered as cytocompatible with a viability of more than 70% of the negative control, which indicates the non-toxic range as defined in current, international standards (DIN EN ISO 10993-5:2009, German Institute for Standardization, Berlin, Germany). Direct live-dead staining assays confirmed satisfactory cytocompatibility of all tested membranes. Conclusion: All examined bone substitute materials and membranes were found to be cytocompatible. In order to assess whether the observed minor differences can impact regenerative processes, further in vivo studies need to be conducted.